RecruitingNCT05111015

Tracking Results of Ablations to Combat AF Registry Generation 2

Sponsor

AtriCure, Inc.

Enrollment

10,000 participants

Start Date

Feb 1, 2013

Study Type

OBSERVATIONAL

Conditions

Atrial Fibrillation

Summary

The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry study tracking real-world outcomes for people who have undergone catheter ablation for atrial fibrillation — a procedure that uses energy (heat or cold) to correct abnormal electrical pathways in the heart — to understand long-term results. **You may be eligible if...** - You have been scheduled for or have already undergone a cardiac ablation procedure for atrial fibrillation - You are 18 years or older (or of legal age in your state or country) - You are willing to provide informed consent **You may NOT be eligible if...** - You have medical, social, or psychological conditions that prevent you from giving consent or following the study protocol Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOpen Concomitant Surgical Ablation Procedures

AtriCure's Open Concomitant Surgical Ablation Devices used for the management of Atrial Fibrillation.

DEVICEHybrid (Convergent) Ablation Procedures

AtriCure's Hybrid (Convergent) Ablation Devices used for the management of Atrial Fibrillation.

DEVICEAtriCure Hybrid Totally Thoracoscopic Ablation Procedures

AtriCure's Hybrid Totally Thoracoscopic Surgical Ablation Devices used for the management of Atrial Fibrillation.

DEVICEAtriCure LAA Exclusion Procedures

AtriCure's LAA Exclusion Devices used to exclude the Left Atrial Appendage for the management of Atrial Fibrillation.

Locations(28)

Huntsville Hospital

Huntsville, Alabama, United States

St. Bernards Medical Center

Jonesboro, Arkansas, United States

CHI St. Vincent Heart Institute

Little Rock, Arkansas, United States

Loma Linda University Medical Center

Loma Linda, California, United States

Adventist Heart Institute (St. Helena Hospital)

St. Helena, California, United States

Valley View Hospital

Glenwood Springs, Colorado, United States

MedStar Washington Hospital

Washington D.C., District of Columbia, United States

Delray Medical Center

Delray Beach, Florida, United States

University of Florida

Gainesville, Florida, United States

Orlando Health Heart & Vascular Institute

Orlando, Florida, United States

St. Joseph's Hospital (BayCare)

Tampa, Florida, United States

Franciscan Health

Indianapolis, Indiana, United States

Kansas City Heart Rhythm Institute

Overland Park, Kansas, United States

Norton Heart & Vascular Institute

Louisville, Kentucky, United States

University of Michigan

Ann Arbor, Michigan, United States

Corewell Health

Grand Rapids, Michigan, United States

Washington University School of Medicine

St Louis, Missouri, United States

University of Nebraska Medical Center

Omaha, Nebraska, United States

Maimonides Health Heart & Vascular Institute

Brooklyn, New York, United States

Vassar Brothers Medical Center

Poughkeepsie, New York, United States

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, United States

UH Cleveland Harrington Heart & Vascular Institute

Cleveland, Ohio, United States

Jackson Madison County General Hospital

Jackson, Tennessee, United States

Centennial Medical Center

Nashville, Tennessee, United States

Michael E. DeBakey VAMC - Houston

Houston, Texas, United States

Medical College of Wisconsin

Milwaukee, Wisconsin, United States

Nova Scotia Health Authority

Halifax, Nova Scotia, Canada

Waterloo Regional Health Network

Kitchener, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05111015

Related Trials

Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation

NCT055575262 locations

Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

NCT0597668528 locations